Literature DB >> 21282604

Unique inhibitory synapse with particularly rich endocannabinoid signaling machinery on pyramidal neurons in basal amygdaloid nucleus.

Takayuki Yoshida1, Motokazu Uchigashima, Miwako Yamasaki, Istvan Katona, Maya Yamazaki, Kenji Sakimura, Masanobu Kano, Mitsuhiro Yoshioka, Masahiko Watanabe.   

Abstract

2-Arachidonoylglycerol (2-AG) is the endocannabinoid that mediates retrograde suppression of synaptic transmission in the brain. 2-AG is synthesized in activated postsynaptic neurons by sn-1-specific diacylglycerol lipase (DGL), binds to presynaptic cannabinoid CB(1) receptors, suppresses neurotransmitter release, and is degraded mainly by monoacylglycerol lipase (MGL). In the basolateral amygdala complex, it has been demonstrated that CB(1) is particularly enriched in axon terminals of cholecystokinin (CCK)-positive GABAergic interneurons, induces short- and long-term depression at inhibitory synapses, and is involved in extinction of fear memory. Here, we clarified a unique molecular convergence of DGLα, CB(1), and MGL at specific inhibitory synapses in the basal nucleus (BA), but not lateral nucleus, of the basolateral amygdala. The synapses, termed invaginating synapses, consisted of conventional symmetrical contact and unique perisynaptic invagination of nerve terminals into perikarya. At invaginating synapses, DGLα was preferentially recruited to concave somatic membrane of postsynaptic pyramidal neurons, whereas invaginating presynaptic terminals highly expressed CB(1), MGL, and CCK. No such molecular convergence was seen for flat perisomatic synapses made by parvalbumin-positive interneurons. On the other hand, DGLα and CB(1) were expressed weakly at axospinous excitatory synapses. Consistent with these morphological data, thresholds for DGLα-mediated depolarization-induced retrograde suppression were much lower for inhibitory synapses than for excitatory synapses in BA pyramidal neurons. Moreover, depolarization-induced suppression was readily saturated for inhibition, but never for excitation. These findings suggest that perisomatic inhibition by invaginating synapses is a key target of 2-AG-mediated control of the excitability of BA pyramidal neurons.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21282604      PMCID: PMC3041100          DOI: 10.1073/pnas.1012875108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  Retrograde endocannabinoid signaling in a postsynaptic neuron/synaptic bouton preparation from basolateral amygdala.

Authors:  Ping Jun Zhu; David M Lovinger
Journal:  J Neurosci       Date:  2005-06-29       Impact factor: 6.167

Review 2.  Cortical pathways to the mammalian amygdala.

Authors:  A J McDonald
Journal:  Prog Neurobiol       Date:  1998-06       Impact factor: 11.685

3.  Depolarization-induced suppression of inhibition mediated by endocannabinoids at synapses from fast-spiking interneurons to medium spiny neurons in the striatum.

Authors:  Madoka Narushima; Motokazu Uchigashima; Kouichi Hashimoto; Masahiko Watanabe; Masanobu Kano
Journal:  Eur J Neurosci       Date:  2006-10-17       Impact factor: 3.386

4.  Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum.

Authors:  Motokazu Uchigashima; Madoka Narushima; Masahiro Fukaya; Istvan Katona; Masanobu Kano; Masahiko Watanabe
Journal:  J Neurosci       Date:  2007-04-04       Impact factor: 6.167

5.  Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor.

Authors:  Takayuki Yoshida; Masahiro Fukaya; Motokazu Uchigashima; Eriko Miura; Haruyuki Kamiya; Masanobu Kano; Masahiko Watanabe
Journal:  J Neurosci       Date:  2006-05-03       Impact factor: 6.167

6.  Tonic enhancement of endocannabinoid-mediated retrograde suppression of inhibition by cholinergic interneuron activity in the striatum.

Authors:  Madoka Narushima; Motokazu Uchigashima; Masahiro Fukaya; Minoru Matsui; Toshiya Manabe; Kouichi Hashimoto; Masahiko Watanabe; Masanobu Kano
Journal:  J Neurosci       Date:  2007-01-17       Impact factor: 6.167

Review 7.  The role of the hippocampus in mediating emotional responses to nicotine and cannabinoids: a possible neural substrate for functional interactions.

Authors:  María-Paz Viveros; Eva-María Marco; Ricardo Llorente; Laura Lamota
Journal:  Behav Pharmacol       Date:  2007-09       Impact factor: 2.293

8.  Serotonin-immunoreactive axon terminals innervate pyramidal cells and interneurons in the rat basolateral amygdala.

Authors:  Jay F Muller; Franco Mascagni; Alexander J McDonald
Journal:  J Comp Neurol       Date:  2007-11-20       Impact factor: 3.215

9.  The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum.

Authors:  Yoshinobu Kawamura; Masahiro Fukaya; Takashi Maejima; Takayuki Yoshida; Eriko Miura; Masahiko Watanabe; Takako Ohno-Shosaku; Masanobu Kano
Journal:  J Neurosci       Date:  2006-03-15       Impact factor: 6.167

10.  Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice.

Authors:  A Zimmer; A M Zimmer; A G Hohmann; M Herkenham; T I Bonner
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

View more
  63 in total

1.  Chronic alcohol exposure disrupts CB1 regulation of GABAergic transmission in the rat basolateral amygdala.

Authors:  Florence P Varodayan; Michal Bajo; Neeraj Soni; George Luu; Samuel G Madamba; Paul Schweitzer; Marisa Roberto
Journal:  Addict Biol       Date:  2016-01-20       Impact factor: 4.280

2.  Glial control of endocannabinoid heterosynaptic modulation in hypothalamic magnocellular neuroendocrine cells.

Authors:  Shi Di; Ion R Popescu; Jeffrey G Tasker
Journal:  J Neurosci       Date:  2013-11-13       Impact factor: 6.167

3.  Fear extinction causes target-specific remodeling of perisomatic inhibitory synapses.

Authors:  Stéphanie Trouche; Jennifer M Sasaki; Tiffany Tu; Leon G Reijmers
Journal:  Neuron       Date:  2013-10-31       Impact factor: 17.173

Review 4.  Invaginating Presynaptic Terminals in Neuromuscular Junctions, Photoreceptor Terminals, and Other Synapses of Animals.

Authors:  Ronald S Petralia; Ya-Xian Wang; Mark P Mattson; Pamela J Yao
Journal:  Neuromolecular Med       Date:  2017-06-13       Impact factor: 3.843

5.  Anandamide Signaling Augmentation Rescues Amygdala Synaptic Function and Comorbid Emotional Alterations in a Model of Epilepsy.

Authors:  Roberto Colangeli; Maria Morena; Quentin J Pittman; Matthew N Hill; G Campbell Teskey
Journal:  J Neurosci       Date:  2020-06-29       Impact factor: 6.167

Review 6.  Endocannabinoid signaling in the amygdala: anatomy, synaptic signaling, behavior, and adaptations to stress.

Authors:  T S Ramikie; S Patel
Journal:  Neuroscience       Date:  2011-08-22       Impact factor: 3.590

Review 7.  Structure, Distribution, and Function of Neuronal/Synaptic Spinules and Related Invaginating Projections.

Authors:  Ronald S Petralia; Ya-Xian Wang; Mark P Mattson; Pamela J Yao
Journal:  Neuromolecular Med       Date:  2015-05-26       Impact factor: 3.843

8.  Endocannabinoid signaling within the basolateral amygdala integrates multiple stress hormone effects on memory consolidation.

Authors:  Piray Atsak; Daniela Hauer; Patrizia Campolongo; Gustav Schelling; Raquel V Fornari; Benno Roozendaal
Journal:  Neuropsychopharmacology       Date:  2014-12-30       Impact factor: 7.853

Review 9.  Neurobiological Interactions Between Stress and the Endocannabinoid System.

Authors:  Maria Morena; Sachin Patel; Jaideep S Bains; Matthew N Hill
Journal:  Neuropsychopharmacology       Date:  2015-06-12       Impact factor: 7.853

Review 10.  Endocannabinoid Signaling in the Central Amygdala and Bed Nucleus of the Stria Terminalis: Implications for the Pathophysiology and Treatment of Alcohol Use Disorder.

Authors:  Gaurav Bedse; Samuel W Centanni; Danny G Winder; Sachin Patel
Journal:  Alcohol Clin Exp Res       Date:  2019-08-21       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.